Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026 Scheduled to present retinal vascular research on SZN-8141 at the upcoming 2026 ARVO Annual ...
In an updated report earlier in the week, the company said that it grew its revenues by 40 percent last year to $176 million ...
Income from operations was RMB2.9 million (US$0.4 million) in the fourth quarter of 2025, compared with a loss from operations of RMB152.7 million in the same period of 2024. For the year ended ...
Interview:SAS’s Reggie Townsend argues that AI’s future depends on trust, cultural fit, fair value sharing, and rules that ...
After a rough Q4 FY 2025 earnings, Ralliant's stock has reached an all-time low. Yet, one of the company's board directors ...
The only weight many people are think about is the number they see when they step on a scale. While that number can obviously ...
LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service ...
The Ambitious Australia report concluded the nation is short of focus, coordination, and pathways that turn effort into outcomes at scale. That finding lands squarely in agriculture.
Ten stocks stood firmer week-on-week, boasting double-digit gains despite a market bloodbath, as investors loaded positions ...
Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for ...
There’s a moment every psychiatrist recognizes. A patient sits down. You have 20 minutes. But their life is not 20 minutes ...
Early lessons learned from California’s Equity and Practice Transformation program can provide a roadmap for other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results